ResMed Inc.
RMD
$208.05
-$0.93-0.45%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.52B | 1.49B | 1.44B | 1.40B | 1.31B |
| Total Depreciation and Amortization | 237.75M | 220.80M | 214.36M | 210.34M | 190.39M |
| Total Amortization of Deferred Charges | 25.57M | 25.40M | 25.41M | 25.47M | 25.89M |
| Total Other Non-Cash Items | 114.20M | 108.43M | 104.30M | 98.32M | 108.30M |
| Change in Net Operating Assets | -7.12M | 74.00M | 101.39M | 16.74M | 15.11M |
| Cash from Operations | 1.89B | 1.91B | 1.88B | 1.75B | 1.65B |
| Capital Expenditure | -135.74M | -122.89M | -114.99M | -89.87M | -84.16M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -163.98M | -139.10M | -139.77M | -139.25M | -20.37M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.47M | -7.03M | -9.00K | 29.07M | -8.31M |
| Cash from Investing | -295.26M | -269.02M | -254.77M | -200.05M | -112.84M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -10.00M | -10.00M | -10.00M | -40.00M | -335.00M |
| Issuance of Common Stock | 75.35M | 76.94M | 74.26M | 74.44M | 71.98M |
| Repurchase of Common Stock | -622.08M | -522.04M | -418.44M | -318.10M | -267.93M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -340.16M | -330.63M | -320.74M | -310.88M | -303.84M |
| Other Financing Activities | -10.86M | -10.86M | -10.86M | -11.71M | -855.00K |
| Cash from Financing | -907.75M | -796.58M | -685.77M | -606.25M | -835.65M |
| Foreign Exchange rate Adjustments | 40.85M | 46.23M | 14.66M | 25.80M | -9.65M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 727.80M | 895.13M | 957.49M | 971.09M | 694.80M |